Eurofins Viracor
Eurofins Viracor is a U.S. specialty clinical diagnostics laboratory providing nearly 3,000 molecular and immunology assays for infectious disease, transplant, and allergy testing, serving about 75% of U.S. transplant programs, 550 institutional clients, and 12 pharmaceutical companies as a Eurofins Scientific subsidiary.
- Company typePrivate
- Founded1984
- HeadquartersLenexa, Kansas, United States
- Headcount251–500
- GTM typeB2B
- OfferingServices
What Eurofins Viracor does
Eurofins Viracor is a specialty clinical diagnostics laboratory headquartered in Lenexa, Kansas, with a satellite facility in Los Angeles, operating as a wholly-owned subsidiary of Eurofins Scientific following a 2014 acquisition valued at approximately $255 million. The company traces its lineage to ViraCor Laboratories and IBT Laboratories, both founded in 1984, which merged in 2009 and were subsequently extended through the 2013 acquisitions of Cylex (ImmuKnow assay) and the National Institute of Transplantation's HLA laboratory.
The laboratory delivers a test menu of nearly 3,000 assays concentrated in infectious disease, immunology, transplant diagnostics, and allergy testing, with core technology platforms spanning quantitative PCR, hybrid-capture next-generation sequencing (NeXGen Fungal/AFB NGS), DNA sequencing, ELISA, and immunoassays — including proprietary, brand-protected assays such as ExPeCT CAR T-cell persistence monitoring, TTViWATCH Torque Teno Virus viral load, TA-TMA complement pathway testing, and ImmuKnow immune cell function assessment. Differentiated offerings include the first commercially available Alpha-Gal IgE assay and a respiratory pathogen panel delivering same-day results in 8-12 hours.
The commercial model is B2B enterprise reference laboratory testing billed primarily through CPT codes on a pay-as-you-go basis, sold via direct field sales and an online ordering/results portal to approximately 550 institutional clients including hospitals, transplant programs (75% of all U.S. transplant programs), 4,000+ affiliated clinicians, reference laboratories, and 12 leading pharmaceutical companies for clinical trial support and biomarker testing. The business holds CAP Accreditation, CLIA high-complexity certification, and EU/U.K./Swiss Data Privacy Framework certifications, supporting both clinical and BioPharma service delivery.
Eurofins Viracor firmographics
Firmographics- Name
- Eurofins Viracor
- Legal name
- Eurofins Viracor, LLC
- Website
- https://eurofins-viracor.com
- Company type
- Private
- Founded year
- 1984
- Operating status
- Operating
- Headcount range
- 251–500 employees
- Short description
- Eurofins Viracor is a U.S. specialty clinical diagnostics laboratory providing nearly 3,000 molecular and immunology assays for infectious disease, transplant, and allergy testing, serving about 75% of U.S. transplant programs, 550 institutional clients, and 12 pharmaceutical companies as a Eurofins Scientific subsidiary.
- Ownership category
- akta.pro rank
Eurofins Viracor industry classification
Industry- Product category
- Specialty Clinical Diagnostics
- NAICS
- Medical Laboratories (621511)
- SIC
- Services-Medical Laboratories (8071)
- akta.pro primary industry
- Microbiology & Infectious Disease Testing Laboratories (HLAFAMAD)
- akta.pro secondary industries
- Clinical Chemistry & Immunoassay Laboratories (HLAFAMAB), Central Laboratory Services (Core Lab Operations) (HLAGAEAA)
Keywords
Where Eurofins Viracor is headquartered
LocationHeadquarters
- HQ city
- Lenexa, Kansas
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
Eurofins Viracor business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Operations, Infrastructure, Marketing or Sales
Revenue model
- Clinical Laboratory Testing Services: Specialty diagnostic laboratory testing services for infectious disease, immunology, transplant, and allergy testing; operates as a reference laboratory providing diagnostic results to healthcare providers; revenue generated through test fees billed to hospitals, physicians, and pharmaceutical companies
- Pharmaceutical/Biotech Services: Clinical trial support and specialized testing services for 12 leading pharmaceutical companies including biologic and large molecular biomarker support
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Pay-as-you-go | Clinical diagnostic testing services for healthcare providers |
Go-to-market motion2 records
Distribution channels2 records
Marketing channels4 records
Eurofins Viracor product offering
Product offeringCore offering
Eurofins Viracor operates a specialty clinical diagnostics laboratory offering nearly 3,000 assays spanning infectious disease, immunology, transplant, and allergy testing. The laboratory provides diagnostic services to hospitals, transplant programs, physicians, reference laboratories, and pharmaceutical companies using molecular diagnostics (quantitative PCR, next-generation sequencing), immunoassay platforms, and proprietary technologies such as TEM-PCR and hybrid-capture NGS. Test results are delivered with industry-leading turnaround times of 8–12 hours for infectious disease panels.
Product overview
Eurofins Viracor is a specialty clinical diagnostics laboratory offering a comprehensive test menu of nearly 3000 assays for infectious disease, immunology, transplant, and allergy testing. The company operates as part of the Eurofins network and provides advanced molecular diagnostic solutions including real-time PCR, next-generation sequencing (NGS), and immunoassay platforms. Key products include the ExPeCT™ CAR T-cell monitoring assays, NeXGen™ Fungal/AFB NGS hybrid-capture sequencing, TTViWATCH viral load monitoring, TA-TMA complement pathway testing, ImmuKnow® immune cell function assessment, inSIGHT T Cell Immunity testing, NTM RT-PCR panels, and comprehensive respiratory panels utilizing proprietary TEM-PCR™ technology. The company serves immunocompromised and critically ill patients with industry-leading turnaround times of 8-12 hours for infectious disease testing. Their portfolio spans infectious disease diagnostics (CMV, COVID-19, HIV, fungal infections), immunology monitoring (CAR T therapy, transplant rejection), allergy testing, and BioPharma research services.
Differentiator
Problem solved
Functional benefit
Brands
- ExPeCT: CAR T-cell persistence and expansion assays for monitoring CAR T-cell therapy efficacy
- NeXGen
- TTViWATCH
- TA-TMA
- TEM-PCR
Products and services
- ExPeCT™ anti-CD19 CAR T-Cell Assays Specialized diagnostic assays designed to monitor patients undergoing CAR T-cell therapy by evaluating the persistence and function of CAR T cells, providing critical insights into therapy effectiveness for personalized treatment decisions in cancer care.
- NeXGen™ Fungal / AFB NGS Assay Hybrid-capture next-generation sequencing assay offering comprehensive detection of fungal pathogens and acid-fast bacteria with increased sensitivity and specificity, enabling simultaneous detection of multiple pathogens from a single clinical specimen.
- TTViWATCH Torque Teno Virus qPCR Quantitative PCR assay for detecting Torque Teno Virus (TTV) in patient samples, providing valuable insights into immune status and viral load for monitoring immunocompromised patients undergoing transplant or cancer therapies.
- TA-TMA Comprehensive Assay Suite Comprehensive assay suite for assessing complement pathway regulation in stem cell transplant patients, with validated assays for Eculizumab monitoring, CH50, and sC5b-9 to support clinicians in optimizing patient management.
- ImmuKnow® Immune Cell Function Assay Non-invasive biomarker assay that assesses cellular immune status by detecting cell-mediated immunity (CMI) in populations undergoing immunosuppressive therapy for organ transplant, helping clinicians optimize immunosuppression regimens.
- inSIGHT T Cell Immunity Testing T cell immunity testing services for monitoring immune responses in transplant and immunocompromised patients, including CMV and EBV-specific T cell assessments.
- aGVHD (Acute Graft-versus-Host Disease) Testing Diagnostic testing for assessing and monitoring acute graft-versus-host disease in transplant patients, including biomarker panels and algorithms for pre-symptomatic and symptomatic detection.
- NTM Nontuberculous Mycobacteria RT-PCR Panel RT-PCR assays for rapid detection and differentiation of MAC (Mycobacterium avium complex), MAbC (Mycobacterium abscessus complex), and Mycobacterium spp. from lower respiratory specimens.
- Respiratory Pathogen Panel TEM-PCR™ Comprehensive multiplex PCR panel (Test Code 220000) detecting respiratory pathogens including bacteria and viruses with same-day results within 8–12 hours from specimen receipt.
- CMV (Cytomegalovirus) Testing Comprehensive CMV diagnostics including quantitative PCR, resistance testing, T cell immunity testing, and antibody detection for managing CMV infections in immunocompromised patients.
- Fungal Testing Services Comprehensive fungal diagnostics including Aspergillus PCR Panel, Fungitell® β-D-Glucan Assay, Histoplasma Galactomannan EIA, and fungal PCR profiles for detecting invasive fungal infections.
- Alpha-Gal IgE Assay First commercially available assay to detect IgE antibodies against galactose-alpha-1,3-galactose for identifying delayed-onset allergic reactions to red meat associated with tick bites.
- Allergy Testing Extensive allergy and immunology testing menu including IgE and IgG antibody testing for environmental allergens, food allergens, drug allergies, and component-resolved diagnostics.
- BioPharma Services Specialized diagnostic testing services for biopharmaceutical companies supporting clinical trials and therapeutic development, including custom assay development and validation for complex clinical research testing in therapeutics, vaccines, and cell and gene therapies.
- COVID-19 Testing Coronavirus SARS-CoV-2 RT-PCR testing services for detecting COVID-19 infection in patient samples.
Quantifiable outcome
- Infectious disease testing turnaround time: 8-12 hours from specimen receipt (same day results)
- +2 more outcomes
Companies that use Eurofins Viracor
Customer profileNamed customers4 records
Segments3 records
Ideal customer profiles3 records
Eurofins Viracor technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature6 records
Eurofins Viracor partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered core.
- National Institute of Transplantation (NIT)coreViracor-IBT acquired assets of the National Institute of Transplantation including their Los Angeles-based serology and HLA laboratory operations. This expanded testing capabilities to include pre-transplant testing complementing Viracor-IBT's post-transplant diagnostics.
- Cylex, Inc.coreViracor-IBT acquired assets of Cylex, Inc. including the ImmuKnow immune monitoring assay. Cylex was a global life sciences company focused on in vitro diagnostic products for transplant medicine immunity testing.
Scale indicators7 records
Recent moves6 records
Expansion highlights5 records
Eurofins Viracor competitors and assessment
Company assessmentDirect peers
- NeoGenomics: NeoGenomics is a specialty oncology reference laboratory offering molecular, NGS, and immune monitoring testing to oncologists, hospitals, and pharma. Comparable to Eurofins Viracor's specialty testing for immunocompromised/cancer patients and biopharma clinical trial services.
- ARUP Laboratories: ARUP is a non-profit specialty reference laboratory affiliated with the University of Utah, serving hospitals and transplant centers with esoteric and immunology testing. Directly comparable to Eurofins Viracor's transplant/immunology specialty reference lab business model.
- Mayo Clinic Laboratories: Mayo Clinic Laboratories is the reference laboratory of Mayo Clinic, offering esoteric specialty testing to hospitals and transplant programs worldwide. Comparable to Eurofins Viracor's transplant, infectious disease, and immunology specialty testing services.
- Sonic Healthcare USA: Sonic Healthcare USA operates specialty and routine reference laboratories (including CPL, Sunrise Medical Labs, and others) serving hospitals and physicians. Comparable to Eurofins Viracor's reference laboratory model in clinical diagnostic services.
Emerging players
- Natera: Natera develops cell-free DNA-based tests for transplant rejection monitoring (Prospera), oncology, and women's health. Comparable to Eurofins Viracor's transplant and immunology monitoring franchise with a competing technology approach.
- Bio-Techne: Bio-Techne manufactures diagnostic reagents, immunoassays, and analytical tools used in research and clinical labs. Comparable to Eurofins Viracor's specialty assay development and broader Eurofins network bio-analytical testing capabilities.
- Adaptive Biotechnologies: Adaptive Biotechnologies offers immune repertoire sequencing (clonoSEQ, immunoSEQ) for cancer and immune monitoring. Comparable to Eurofins Viracor's ExPeCT CAR T-cell and ImmuKnow immune cell function assays in immune monitoring diagnostics.
Broad incumbents
- Laboratory Corporation of America (LabCorp): LabCorp is one of the largest U.S. clinical reference laboratories offering routine and specialty diagnostics to hospitals, physicians, and pharma. Overlaps broadly with Eurofins Viracor's clinical and biopharma testing offerings as a larger incumbent.
- Quest Diagnostics: Quest Diagnostics is the largest U.S. clinical reference laboratory with a broad specialty and routine test menu serving hospitals and physicians. Overlaps with Eurofins Viracor's hospital-facing clinical diagnostic services as a larger incumbent.
Others
- Eurofins Scientific (parent): Eurofins Scientific is the publicly-traded parent company of Eurofins Viracor, operating a global network of bio-analytical, clinical, and genomic testing laboratories. Included as the parent entity whose portfolio overlaps with Eurofins Viracor's clinical and biopharma testing capabilities.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
Eurofins Viracor social profiles
Digital presenceEurofins Viracor compliance and trust
Trust signalCompliance5 records
Eurofins Viracor financial estimates
Financial estimateRevenue estimate
Valuation estimate
Eurofins Viracor leadership team
Management profileNumber of profiles
Profiles4 records
Eurofins Viracor subsidiaries and ownership
Company hierarchySubsidiaries2 records
Eurofins Viracor funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Eurofins Viracor M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Eurofins Viracor
What does Eurofins Viracor do?
Eurofins Viracor operates a specialty clinical diagnostics laboratory offering nearly 3,000 assays spanning infectious disease, immunology, transplant, and allergy testing. The laboratory provides diagnostic services to hospitals, transplant programs, physicians, reference laboratories, and pharmaceutical companies using molecular diagnostics (quantitative PCR, next-generation sequencing), immunoassay platforms, and proprietary technologies such as TEM-PCR and hybrid-capture NGS. Test results are delivered with industry-leading turnaround times of 8–12 hours for infectious disease panels.
Is Eurofins Viracor a public or private company?
Eurofins Viracor is a private company. It is classified as corporate owned and is currently operating.
When was Eurofins Viracor founded?
Eurofins Viracor was founded in 1984. It employs 251 to 500 people.
Where is Eurofins Viracor based?
Eurofins Viracor is headquartered in Lenexa, Kansas, United States, in the North America region.
How does Eurofins Viracor make money?
Two revenue lines are on record. Clinical Laboratory Testing Services are the primary driver. The others are pharmaceutical/Biotech Services.
Who are Eurofins Viracor's main competitors?
Direct peers on record are NeoGenomics, ARUP Laboratories, Mayo Clinic Laboratories and Sonic Healthcare USA. Emerging players are Natera, Bio-Techne and Adaptive Biotechnologies. Broad incumbents are Laboratory Corporation of America (LabCorp) and Quest Diagnostics. Eurofins Scientific (parent) is listed as an others.
Does Eurofins Viracor have an API?
No public API is recorded for Eurofins Viracor.
What industry is Eurofins Viracor in?
Eurofins Viracor's product category is Specialty Clinical Diagnostics. Its primary akta.pro industry code is HLAFAMAD, Microbiology & Infectious Disease Testing Laboratories, with a secondary code of HLAFAMAB, Clinical Chemistry & Immunoassay Laboratories. Its NAICS code is 621511 and its SIC code is 8071.